Insmed Inc (INSM)

[ED20332]

NASDAQ to Host Industry Panel on the State of the Worlds AIDS Epidemic
via COMTEX

November 20, 2006

Panel to Take Place On Dec. 1st World AIDS Day From NASDAQ MarketSite Followed by a Closing Bell Ceremony

ADVISORY, Nov 20, 2006 (PrimeZone Media Network via COMTEX News Network) --




What: The NASDAQ Stock Market will host an industry panel
luncheon and discussion focused on new research in the
fight against Acquired Immunodeficiency Syndrome (AIDS).

The panel will include industry experts and executives
from NASDAQ-listed Biotechnology companies that will
cover an array of industry topics ranging from prevention
and viral resistance, to quality of life treatments.

Following the panel discussion, there will be a NASDAQ
Closing Bell Ceremony in honor of World AIDS Day with
our panel members and NASDAQ representatives.

Who: Moderator:
---------
-- Emilio A. Emini, Ph.D. Executive Vice President,
Vaccine Research and Development for Wyeth
Pharmaceuticals

Panelists:
---------
-- Geoff Allan, Chief Executive Officer, President and
Chief Executive Officer of Insmed Incorporated
(Nasdaq:INSM)

-- Paul J. Maddon, M.D., Ph.D., Founder, Chief Executive
Officer and Chief Science Officer, Progenics
Pharmaceuticals, Inc. (Nasdaq:PGNX)

-- Douglas A. Michels, President & Chief Executive
Officer at OraSure Technologies, Inc. (Nasdaq:OSUR)

-- George Usher, Chairman, President and Chief Executive
Officer, Polydex Pharmaceuticals Limited (Nasdaq:POLXF).

When: Friday, December 1st, 2006
1:30 p.m. - 2:00 p.m. - Lunch
2:00 p.m. - 3:30 p.m. - Panel Discussion
3:30 p.m. - 4:00 p.m. - NASDAQ Closing Bell

Reporters, analysts, and other industry members are welcome
to attend.

Where: NASDAQ MarketSite
4 Times Square (Corner of 43rd and Broadway)
New York, NY

Contacts: Silvia Davi
646-441-5014
[e-mail]

Jolene Libretto
646-441-5220
[e-mail]

RSVP: Interested parties should RSVP to Jolene Libretto
[e-mail]